Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology. - Wikidata - wikimedia - TriplyDB

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q43467553

about

Untangling tau imaging Insight into the Molecular Imaging of Alzheimer's Disease Characteristics of Tau and Its Ligands in PET Imaging Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging Imaging pathological tau in atypical parkinsonian disorders Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection Current understanding of chronic traumatic encephalopathy Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Imaging frontotemporal lobar degeneration.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Antibody-derived in vivo imaging of tau pathology.Tau PET imaging: present and future directions.Imaging biomarkers associated with cognitive decline: a review.In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.In vivo quantification of cochlin in glaucomatous DBA/2J mice using optical coherence tomography.Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.PET Radioligands for Imaging of Tau Pathology: Current Status.Tau positron emission tomographic imaging in aging and early Alzheimer disease Tau imaging in neurodegenerative diseases.PET imaging of neuropathology in tauopathies: progressive supranuclear palsy Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.Harnessing the immune system for treatment and detection of tau pathology.In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.Tau PET imaging in Alzheimer's disease.Developments in Tau PET Imaging.In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Genetics of Frontotemporal Dementia.Biomarkers in Neurodegenerative Diseases.Imaging tau pathology in Parkinsonisms.Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly.Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.Biomathematical screening of amyloid radiotracers with clinical usefulness index.In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.

P2860

Q26739091-A196C1C5-C1C4-402A-9266-3D701670DE77 Q26765945-6C30C2D8-B709-4C2B-977F-F59570EC7243 Q26769952-9D655AFC-F49A-4BB8-B913-4B250445FD56 Q26770766-76866958-09DA-41A3-A407-AFA82277F6E3 Q26823039-CD064AC6-E182-4AF9-94C6-F1F9C95B30D2 Q27003078-8FEB9CE6-70AB-4032-A886-F78699BB608B Q28075227-EA5BD81E-BACC-4B1C-A03E-828E6BF2926B Q28241366-ADCBA78C-AF06-4C91-B4C4-8248892F3E33 Q28383546-EEC1603B-A278-4624-81AC-41A1E354AD4F Q30275833-AB78FAAB-AF87-412B-94B6-5078FD09EF31 Q30846573-DCD81CA4-A140-472D-8942-214BA8BD6AE4 Q30996799-A2731042-4AF5-4445-A2DE-BE8488E74691 Q34664345-275797DE-9466-4699-ACCE-BC417D122651 Q34680852-03FCBDAF-87F1-4696-B727-AA6145739E56 Q35185786-F085BC92-CD33-4F08-B356-E549C4400587 Q35549386-F4C2ECDE-5BC5-4E4A-89B0-F666C62C3572 Q35687425-6F9994B8-B92A-4BF0-9D1D-7A3AAEB213A8 Q35804873-8DE70ADC-B54E-4F17-A9CA-BAC33337C511 Q35810005-72DDCA8F-A846-4A84-890B-ABB2B7FA825E Q36241261-0F857C27-8ABA-4FBE-B070-C0BFB87523E9 Q36535275-E35ED382-FAC6-42E2-B949-CFD7EB4AF5A6 Q36834567-1E606536-EB93-4D2F-8474-F02DE76C5988 Q36906654-3E064895-D716-4A6F-B5EB-12BFB0CC3840 Q37691087-EC33210E-8FE3-4FCB-BF14-5F3CF4EF55C5 Q38194049-EF25A9D5-FDC1-4D9C-BE89-0CDAED455438 Q38195938-364B85C6-C873-469B-8966-194DB656B375 Q38252750-B78F34CF-BB11-43BA-9B8F-FAAB149CFBE8 Q38271405-F18CDED2-FAF3-4A63-83F2-FCC821A50977 Q38436447-6D11BC45-A2CA-495B-A029-2111FDD40D58 Q38810544-8FA682C2-1882-4A27-A258-C4CE660A06EB Q38836004-5F15AF9F-91F7-451E-A491-B1C71F78B2DA Q38979999-306F5372-444D-4A0B-8D36-975A8FAC38BC Q39017699-07D3C00C-56E0-4A5A-AAAE-D1FE9BD0361B Q39413097-AA2438D3-6846-46C8-BC2F-FEE8B96D544D Q39419877-5FCA6CA8-86DB-4794-AC82-694AAAF17B87 Q39429271-F0D8B678-E004-4D60-83B0-334CAF94C650 Q39544835-48260B14-2CFD-4F12-A3A1-876CF135DF70 Q41535994-9A704D78-0BEE-4772-9E1C-7FADFBC51EF6 Q47241835-CC5BA7A8-88D0-43CB-A233-CD999F2F05C9 Q47865475-C7ECE3BC-C656-4098-A7C8-363F26A1BB13

P2860

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q43467553

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Comparison of the binding char ...... Alzheimer's disease pathology.

@en

Comparison of the binding char ...... Alzheimer's disease pathology.

@nl

type

label

Comparison of the binding char ...... Alzheimer's disease pathology.

@en

Comparison of the binding char ...... Alzheimer's disease pathology.

@nl

prefLabel

Comparison of the binding char ...... Alzheimer's disease pathology.

@en

Comparison of the binding char ...... Alzheimer's disease pathology.

@nl

P1433

Q43467553-3BF733EC-F42E-45FF-B4F6-3270F9628F5B

P1476

Q43467553-A81114F5-6E23-4C08-A3BE-1258C3775F60

P2093

Q43467553-2F4FAEFD-792D-4528-9073-8CD45D26779D

Q43467553-5206C354-107D-494E-A981-AFCAC85EFF42

Q43467553-58EBEAA6-7AB9-4E98-B478-4338B9962C67

Q43467553-619F76F2-0CEE-4904-A155-2661692C21E1

Q43467553-6239DD58-0144-4CA4-A6A3-C80363950449

Q43467553-6A79298C-11C2-49E4-AAF2-369739EFF4CD

Q43467553-98981696-E1AF-48CA-9328-081E6A37BF3F

Q43467553-B29AFDB8-BB1D-4CFF-9F64-BB202C4366D4

Q43467553-E78D5E56-42D9-4BB7-A554-EDBE8914C807

Q43467553-F8F14C91-7CB5-4E86-A235-4A1E1B21444E

P2860

Q43467553-108C9977-D11F-4483-9A66-9CDB431E6781

Q43467553-1716A159-8D66-4D19-A48D-B5D06BC6BE5C

Q43467553-1F6A9301-2DBE-4CC8-994D-246C56CAFBCE

Q43467553-287BC4C7-D121-42FD-9B71-E095B2238C3B

Q43467553-2C05417F-84B9-45B8-84FC-4C523E042A19

Q43467553-3010AB0F-1EDE-4663-B508-87461EBDA344

Q43467553-3BDEB998-4060-43A9-B14A-87ED301FEB51

Q43467553-43ED5628-3302-4BB7-B5F1-0605510D4719

Q43467553-5AFA7208-A1E0-4F30-98C2-01690736F006

Q43467553-690A843F-ECF6-49DD-B0D9-D77FD3E83F9E

P2888

Q43467553-312AC792-344A-4459-A35B-007C0037E106

P304

Q43467553-A00BE62C-8DA5-4B42-B53C-CA32246D1E5A

P31

Q43467553-9CEF118F-0393-459A-A657-2AC92F2844DA

P356

Q43467553-26995C9A-85D7-4EA7-A2F0-DBEEC23C633C

P433

Q43467553-6A914362-E6E9-498D-BF65-02D918D9491A

P478

Q43467553-2460D889-1942-466B-8D5F-C1961905A133

P50

Q43467553-27961CFC-D8E9-4B24-85B3-AB1B277BCB72

P577

Q43467553-CB594E29-2348-4DF9-B4A8-4D76B182162A

P698

Q43467553-801E8A76-747E-4FAD-88EA-D42751F0AD67

P921

Q43467553-15594e25-d14a-4f4c-b61e-0a4f1536259a

Q43467553-5334ECF2-8498-4FDF-A309-1FD8B865F70A

P356

S00259-012-2261-2

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Comparison of the binding char ...... Alzheimer's disease pathology.

@en

P2093

Hiroyuki Arai

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Yanai

http://www.w3.org/2001/XMLSchema#string

Makoto Higuchi

http://www.w3.org/2001/XMLSchema#string

Masahiro Maruyama

http://www.w3.org/2001/XMLSchema#string

Ren Iwata

http://www.w3.org/2001/XMLSchema#string

Ryuichi Harada

http://www.w3.org/2001/XMLSchema#string

Shozo Furumoto

http://www.w3.org/2001/XMLSchema#string

Takeo Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Tetsuro Tago

http://www.w3.org/2001/XMLSchema#string

Yukitsuka Kudo

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease

Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Recent advances in the development of amyloid imaging agents.

P2888

s00259-012-2261-2

P304

125-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-012-2261-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Nobuyuki Okamura

P577

2012-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23100049

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease